Cargando…
COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles
COVID-19 pandemic will continue to pose a major public health threat until vaccination-mediated herd immunity is achieved. Most projections predict vaccines will reach a large subset of the population late in 2021 or early 2022. In the meantime, countries are exploring options to remove strict lockd...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828180/ https://www.ncbi.nlm.nih.gov/pubmed/33445727 http://dx.doi.org/10.3390/diagnostics11010115 |
_version_ | 1783640948552499200 |
---|---|
author | Ghaffari, Abdi Meurant, Robyn Ardakani, Ali |
author_facet | Ghaffari, Abdi Meurant, Robyn Ardakani, Ali |
author_sort | Ghaffari, Abdi |
collection | PubMed |
description | COVID-19 pandemic will continue to pose a major public health threat until vaccination-mediated herd immunity is achieved. Most projections predict vaccines will reach a large subset of the population late in 2021 or early 2022. In the meantime, countries are exploring options to remove strict lockdown measures and allow society and the economy to return to normal function. One possibility is to expand on existing COVID-19 testing strategies by including large-scale rapid point-of-care diagnostic tests (POCTs). Currently, there is significant variability in performance and features of available POCTs, making selection and procurement of an appropriate test for specific use case difficult. In this review, we have used the World Health Organization’s (WHO) recently published target product profiles (TPPs) for specific use cases of COVID-19 diagnostic tests to screen for top-performing POCTs on the market. Several POCTs, based on clinical sensitivity/specificity, the limit of detection, and time to results, which meet WHO TPP criteria for direct detection of SARS-CoV-2 (acute infection) or indirect diagnosis of past infection (host antibodies), are highlighted here. |
format | Online Article Text |
id | pubmed-7828180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78281802021-01-25 COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles Ghaffari, Abdi Meurant, Robyn Ardakani, Ali Diagnostics (Basel) Review COVID-19 pandemic will continue to pose a major public health threat until vaccination-mediated herd immunity is achieved. Most projections predict vaccines will reach a large subset of the population late in 2021 or early 2022. In the meantime, countries are exploring options to remove strict lockdown measures and allow society and the economy to return to normal function. One possibility is to expand on existing COVID-19 testing strategies by including large-scale rapid point-of-care diagnostic tests (POCTs). Currently, there is significant variability in performance and features of available POCTs, making selection and procurement of an appropriate test for specific use case difficult. In this review, we have used the World Health Organization’s (WHO) recently published target product profiles (TPPs) for specific use cases of COVID-19 diagnostic tests to screen for top-performing POCTs on the market. Several POCTs, based on clinical sensitivity/specificity, the limit of detection, and time to results, which meet WHO TPP criteria for direct detection of SARS-CoV-2 (acute infection) or indirect diagnosis of past infection (host antibodies), are highlighted here. MDPI 2021-01-12 /pmc/articles/PMC7828180/ /pubmed/33445727 http://dx.doi.org/10.3390/diagnostics11010115 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ghaffari, Abdi Meurant, Robyn Ardakani, Ali COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title | COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title_full | COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title_fullStr | COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title_full_unstemmed | COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title_short | COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles |
title_sort | covid-19 point-of-care diagnostics that satisfy global target product profiles |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828180/ https://www.ncbi.nlm.nih.gov/pubmed/33445727 http://dx.doi.org/10.3390/diagnostics11010115 |
work_keys_str_mv | AT ghaffariabdi covid19pointofcarediagnosticsthatsatisfyglobaltargetproductprofiles AT meurantrobyn covid19pointofcarediagnosticsthatsatisfyglobaltargetproductprofiles AT ardakaniali covid19pointofcarediagnosticsthatsatisfyglobaltargetproductprofiles |